Forecast

There is no analyst data available for this company.

News Go to news feed

Telefonica Brasil reports 7.1% revenue growth and higher profits in Q2 2025

Telefonica Brasil (Vivo) increased total revenue in Q2 2025 by 7.1% to 14.6 billion reais and net income by 13.5% to 2.4 billion reais, with an improved EBITDA margin of 40.5%. The company significantly expanded FTTH connections, extended 5G coverage and plans to sell copper and real estate assets worth 4.5 billion reais to finance further investments. » More on de.investing.com
Vivo V60 delivers flagship-level portrait photography at mid-range price

The Vivo V60 pairs Zeiss‑branded 50MP main and telephoto front cameras with Vivo's advanced image processing to produce flagship-quality portrait shots at an estimated $400–$500 price point. It runs on Qualcomm Snapdragon 7 Gen 4 with 12GB RAM, a large 6,500 mAh battery and a premium glass design, trading a mediocre ultra-wide camera for superior telephoto portraits. The review concludes the V60 offers exceptional camera value within the mid-range segment. » More on forbes.com

Historical dividends Dividends

All dividend metrics All metrics

In 2021, VIVO Cannabis has already paid €0.0317 in dividends. The last payout was in June 2021.

Financials

In the last year, VIVO Cannabis had revenue of €17.46M and net profit of -€33.26M

(EUR)	2022	YoY
Revenue	17.46M	0.40%
Gross profit	2.99M	454.42%
Net profit	-33.26M	31.36%
EBITDA	1.32M	102.35%

Fundamentals

Metric	Value
Market capitalization	€5.76M
Number of shares	370.9M
52-week high/low	€0.0466 - €0.00931
Dividends	No
Beta	2.12
P/E ratio	-0.19
PEG ratio	0.01
P/B ratio	0.24
P/S ratio	0.36

Company profile

VIVO Cannabis Inc. produziert und vertreibt Cannabisprodukte für den medizinischen und den Erwachsenenmarkt in Kanada, Deutschland und Australien. Das Unternehmen bietet getrocknete Cannabisblüten, Pre-Rolls und Cannabisöle sowie aus Cannabis gewonnene Produkte unter den Marken Canna Farms, Beacon Medical, Fireside und Lumina an. Das Unternehmen betreibt auch ein Netzwerk von medizinischen Cannabiskliniken unter der Marke Harvest Medicine und die Telemedizin-Plattform HMED Connect, eine Online-Plattform für medizinischen Cannabis. Darüber hinaus beschäftigt sich das Unternehmen mit der Ethanolextraktion, der Produktformulierung und den EU-GMP-bezogenen Prozessen. Der Hauptsitz des Unternehmens befindet sich in Napanee, Kanada.